Discover more from Steve Kirsch's newsletter
Here's the real reason Comirnaty is not available
It's all about liability. It will magically become available when the vaccine for children is fully approved, not before.
The reason Comirnaty isn’t available is because those shots would expose the company to liability since the fully-licensed product doesn’t have the liability waiver of the EUA product.
But once the Pfizer vaccine is fully approved in kids, then Pfizer gets liability waiver on all age groups due to a “feature” in federal law for child vaccines (NCVIA). At that time, they are done. They can market the COVID vaccine products under full approval for all age groups and face no liability when it kills or disables you.
This is why they are focused on the kids. This is why there is a reformulation at a 1/3 dose and they changed the buffer and the storage conditions (low temperatures not required). All of these will weaken the protection, but result in a safer vaccine (since it is ineffective).
But for the clinical trials on the 5-11 year olds, they did not use the formulation they approved in the meeting. This is known as bait and switch. So they used a more effective vaccine to show efficacy (in the trials they completed), then they get the FDA to approve the drug but with a change in formulation, then the product product with the new buffer will go out to the public with the lower efficacy, but better safety. This is because they don’t want to jeopardize any adverse events happening until they are fully approved. So they basically use formula 1 for safety, get approval for formula 2 (safer, less effective), then roll out formula 2 under EUA.
They also arrange with the FDA and CDC to make sure no early treatment drugs get approved or recommended. This is why there is no movement on fluvoxamine, ivermectin, etc. since that would blow the EUA. Fluvoxamine is the best drug ever for COVID with a mortality reduction of 12X when taken early. It’s the best drug to date for COVID, but the CDC and NIH are deliberately burying it until the vaccines are fully approved. Then they’ll say, “ok, we have all the data.”
So at the end, Pfizer gets a fully approved vaccine with full liability protection. At that time, then the NIH can recognize other treatments.
This is how it is wired to go. Let’s be honest about it.
This is why nobody wants to debate our team about what is going on.